Amphetamines Play Role In Baseball Hall Of Famers Death

FORT LAUDERDALE, Fla. (AP) — Baseball Hall of Famer Roy Halladay had high levels of amphetamines in his system and was doing extreme acrobatics when he lost control of his small plane and nosedived into the Gulf of Mexico in 2017, killing him, a National Transportation Safety Board report issued Wednesday said.

 

 

PHILADELPHIA, PA - AUGUST 8: Former Major League pitcher Roy Halladay talks to the media prior to the game between the New York Mets and Philadelphia Phillies on August 8, 2014 at Citizens Bank Park in Philadelphia, Pennsylvania. (Photo by Mitchell Leff/Getty Images)

 

 

Halladay had amphetamine levels about 10 times therapeutic levels in his blood along with a high level of morphine and an anti-depressant that can impair judgement as he performed high-pitch climbs and steep turns, sometimes within 5 feet (1.5 meters) of the water, the report says about the Nov. 7, 2017, crash off the coast of Florida.

The maneuvers put loads of nearly two-times gravity on the plane, an Icon A5 Halladay had purchased a month earlier. On the last maneuver, Halladay entered a steep climb and his speed fell to about 85 miles per hour (135 kph). The propeller-driven plane went into a nosedive and smashed into the water. The report says Halladay, 40, died of blunt force trauma and drowning.

The report does not give a final reason for the crash. That is expected to be issued soon.

About a week before the crash, the former Toronto Blue Jays and Philadelphia Phillies star had flown the plane under Tampa Bay's iconic Skyway Bridge, posting on social media, "flying the Icon A5 over the water is like flying a fighter jet!"

Halladay, an eight-time All-Star and two-time Cy Young Award winner, pitched a perfect game and a playoff no-hitter in 2010. He played for the Blue Jays from 1998 to 2009 and for the Phillies from 2010-13, going 203-105 with a 3.38 ERA. He was inducted into the Hall of Fame posthumously last year.

 

 

PHILADELPHIA, PA - SEPTEMBER 12: Starter Roy Halladay #34 of the Philadelphia Phillies delivers a pitch in the first inning against the San Diego Padres at Citizens Bank Park on September 12, 2013 in Philadelphia, Pennsylvania. (Photo by Drew Hallowell/Getty Images)

 

 

Halladay had taken off from a lake near his home about 15 minutes before the crash and a previous report says he was flying at about 105 mph (170 kph) just 11 feet (3.3 meters) above the water before he started doing his maneuvers. He had about 700 hours of flight time after getting his pilot's license in 2013, the previous report said, including 51 hours in Icon A5s with 14 in the plane that crashed. The report says Halladay was treated for substance abuse twice between 2013 and 2015.

Rolled out in 2014, the A5 is an amphibious aircraft meant to be treated like an ATV, a piece of weekend recreational gear with folding wings that can easily be towed on a trailer to a lake where it can take off from the water.

The man who led the plane's design, 55-year-old John Murray Karkow, died while flying an A5 over California's Lake Berryessa on May 8, 2017, a crash the NTSB attributed to pilot error.

Because of that crash, Icon issued guidance to its owners two weeks before Halladay's accident saying that while low-altitude flying "can be one of the most rewarding and exciting types of flying," it "comes with an inherent set of additional risks that require additional considerations."

 

 

PHILADELPHIA, PA - SEPTEMBER 17: Starter Roy Halladay #34 of the Philadelphia Phillies delivers a pitch against the Miami Marlins in the third inning at Citizens Bank Park on September 17, 2013 in Philadelphia, Pennsylvania. (Photo by Drew Hallowell/Getty Images)

 

 

It added that traditional pilot training focused on high-altitude flying "does little to prepare pilots for the unique challenges of low altitude flying." Icon told the NTSB that Halladay had received and reviewed the guidance.

There is no indication in the report Halladay received low-altitude training.

 

© 2020 Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.